Physician profile
John J Kim
NPI 1063484392
$1,964.73
in general payments reported to CMS, 2019-2025
18 companies · $382 in 2025
The $382 reported for 2025 was more than what 90% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $356 · 2020: $262 · 2021: $311 · 2022: $183 · 2023: $270 · 2024: $201 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $854.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $853.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $273.88 | 2019-2025 | Bexsero, Penmenvy, Trelegy Ellipta |
| Cranial Technologies, INC | $237.60 | 2021-2025 | Doc Band |
| Sanofi Pasteur INC. | $173.09 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $153.23 | 2019-2025 | Gardasil 9, Gardasil, Enflonsia |
| Abbvie INC. | $145.65 | 2019-2022 | |
| Pfizer INC. | $138.90 | 2019-2025 | |
| Genentech USA, INC. | $130.00 | 2020 | |
| Hologic Sales and Service, LLC | $120.83 | 2019 | |
| Sobi, INC | $118.65 | 2019-2024 | |
| Kaleo, INC. | $109.08 | 2019-2021 | |
| Corium, LLC | $82.12 | 2022-2024 | Azstarys |
| Kowa Pharmaceuticals America, INC. | $74.24 | 2025 | Zoryve |
| Supernus Pharmaceuticals, INC. | $73.76 | 2021 | |
| Phadia US INC. | $48.37 | 2022-2025 | Immunocap |
| Boston Scientific Corporation | $44.82 | 2021-2023 | Wavewriter Alpha Prime 16 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $14.31 | 2019 | |
| Seqirus USA INC | $14.12 | 2025 | Flucelvax |
| Ironshore Pharmaceuticals INC. | $12.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.